Nephrologists are often called upon to use drugs of low therapeutic index, in patients with serious diseases and impaired drug excretion. To obtain optimal benefit from these drugs, it is important to adjust both loading and maintenance doses, to yeld appropriate serum concentrations. The loading dose is, of course, dependent upon patient weight (or volume of distribution) and is unchanged in renal or liver failure. Calculating the maintenance dose is slightly more complex. The «standard» drug dosing equations depict an instantaneous, first order relationship between drug concentration (C) and excretion, essentially based on our familiar concept of clearance. where V D = volume of distribution, CIT = normal total body clearance of the drug and C = instantaneous concentration. Solution of this equations yields the familiar formula: Dose and C p = peak concentration (or any other concentration, at start of time t). Unfortunately, recently marketed drugs often have incomplete pharmacokinetic data available for patients with severe renal failure. Even when volume of distribution (V D), half-life (tl/ 2 = 0.693/k), total body clearance (CIT), dialyzer clearance (Cld)' desired «peak» (C p), and «trough» (CT) serum concentrations are known, first-order calculations for proper maintenance dose and interval are somewhat lengthy and require a calculator, computer, or log table.
Considerable simplicity results if we are willing to determine maintenance dose based of the drug. This approach is similar (to that for) creatinine concentrations, which may vary according to daily changes in clearance. A second useful concept is«dosage rate», or the amount of drug given, divided by dosing interval (this «rate» is the same whether analyzed by hour, day or week, and is similar to the «generation rate» used for creatinine.
The Wagner Equation 1 defines the relationship between dose, clearance, and average steady state serum concentration:
CIT x time
Rearranging, dose/time . C ss . CIT' and we see immediately that for the same resultant (ss' dose/time varies in proportion to clearance. The difference between this «average level» equation and the derivativelogarithmic equation is not as large as might be expected. For example, CIT, time, and VD which would result in a fall of C to 25% normal, the C ss equations would predict a fall to 20.4% of normal.
The total clearance of a drug reflects, of course, excretion by both kidney and liver routes: CIT = Cil = CIK' Information on the fraction of drug cleared by liver (Fl) and kidney (F K), is almost uniformly available even for the newest drugs. These data usually are obtained by administration of labelled drug to normal patients, and measuring the urinary excretion of radioactivity over the next 6-72 hours. These data represent the excretion of both the unchanged drug, and its metabolites (which occasionally produce toxicity in renal failure). If it is assumed that the portion of drug not excreted by kidney is excreted by liver, then: Fl = 1-FK' Assuming that both kidney and liver (process) blood of roughly the same -kt Figure 1 , which indicates 100 ml/min clearance as normal kidney drug clearance. This would, of course, be an estimate of normal kidney clearance of drugs which are handled similar to creatinine. Instantaneous hemodialysis clearance of drugs are also indicated (approximately) on this graph, by the number of «*» labels next to the drugs listed at the left. For drugs with significant reabsorption or excretion (Aspirin, or penicillin, for example), the glomerulotubular balance concept suggests that loss of tubular excretion or absorption is proportional to loss of glomerular filtration.
After deciding the proper dosage rate for a patient (from Fig. 1 ), clinical judgement must determine whether the dose or interval should be changed. If it is desirable to maintain normal «peak» and «trough» concentrations' for a drug, administration of the usual maintenance dose at an extended interval is the best way to obtain the appropriate dose rate. The % dose at normal intervals indicated in Figure 1 is also a % of normal difference between peak and through concentrations dose = C -C V P T' D For some drugs, such as cardiovascular agents, consistent serum concentrations are preferred. For these agents a lower maintenance dose should be given at the usual interval (T). However, there is considerable evidence that for antibiotics (especially aminoglycosides) extending the interval, and producing relatively high is peaks the best method of maintaining drug efficacy while minimizing toxicity. There are in several studies over 500 patients with no nephrotoxicity and ototoxicity following aminoglycoside treatment of serious infections (4, 5, 6) . These patients were dosed at varying intervals, to produce gentamicin or tobramycin «through» concentrations below 2 mcg/ml. In severe renal insufficiency the risk of a prolonged, low serum ':roncentration versus the benefit of decreased nephrotoxicity must also be weighed. Another option for drugs highly cleared by dialysis is to provide an additional «peak» serum concentration before dialysis, thus avoiding deleterious effect of a prolonged trough. An example of such dosing, and the resulting serum concentrations has been demonstrated for tobramycin (7) . Another use of the nomogram in Figure 1 is the determination of a post-dialysis «loadinq» dose. For example, if dialysis were to cover an entire normal dosing interval (eg, T = 8 hours), then the proper dose at the end of dialysis would be found at the intersection of CIK + CID on the bottom axis, and FK from the left axis.
For a dialysis lasting half the usual dosing interval (eg, 4 hours), a post-dialysis dose one-half of that indicated by the nomogram would be given, in addition to the between dialysis maintenance dose. For example, a moxalactam post-dialysis dose of 40-60% usual (1-2.4 gm) would be given after an 8 hour dialysis, or 20-30% (0.8-1.2 gm) after a 4 hour dialysis. The maintenance dose rate would then continue between dialyses. The approximate dialysis clearance for many drugs, indicated by «*)) labels, was obtained from a variety of in-dividual studies (8, 29) .
If it is desired to give pre-dialysis «loadinq» doses, these can also be calculated from the Figure 1 monogram. If interdialytic times do not match either the usual or extended intervals indicated, the proper dose would equal the percent dose (at usual interval) multiplied by the number of intervals since the last dialysis. This dose would then yield the appropriate, normal peak concentration.
It behooves gastroenterologists to quantitate appropriate drug dosage for patients with hepatic insufficiency nephrologists have done for patients with renal disfunction. Unfortunately, chemicals such as bilirubin may not be excreted with the same efficiency as drugs. However, ,if a gross estimation of the percent loss of liver clearance (or tissue mass) can be determined, then the nomogram can also be used as a guide to dose rate adjustment in liver failure. The right axis of the Figure 1 monogram indicates the F L normally obtained for the drugs listed in columns on the left side (FL = 1-F K)· Mentally changing the left axis (FK) to become FL' and the top axis to become % of normal liver clearance present, allows the monogram to predict the proper % dose rate for liver failure patients.
This «clearance» approach to drug dosing may appear foreign to some pharmacologists and kineticists. However, it does duplicate and make more exact the type of logic used by clinicians in estimation of drug dosages, and utilizes information readily available on even the newest drugs. The elimination rate constant, the favorite «special k» of most kineticists, is actually derived from the clearance and volume of distribution. Perhaps we would find communication between our fields and clinical teaching of kinetics improved, if we utilized the familiar clearance concept rather than more complicated mathematical models.
